Publications by authors named "Udo Vanhoefer"

Claim this Profile
U
Updated German guideline on diagnosis and treatment of squamous cell carcinoma and adenocarcinoma of the esophagus.
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Udo Vanhoefer

United European Gastroenterol J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Matthias P Ebert, Wolfgang Fischbach, Stephan Hollerbach, Jens Höppner, Dietmar Lorenz, Udo Vanhoefer

Z Gastroenterol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Udo Vanhoefer

Z Gastroenterol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Udo Vanhoefer

Z Gastroenterol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Udo Vanhoefer

Z Gastroenterol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Rainer Porschen, Wolfgang Fischbach, Ines Gockel, Stephan Hollerbach, Arnulf Hölscher, Udo Vanhoefer

Z Gastroenterol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer.
Friederike Braig, Manuela März, Aneta Schieferdecker, Alexander Schulte, Mareike Voigt, Udo Vanhoefer

Oncotarget· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of matuzumab in combination with 5-fluorouracil, leucovorin and cisplatin (PLF) in patients with advanced gastric and esophagogastric adenocarcinomas.
Tanja Trarbach, Marta Przyborek, Norbert Schleucher, Steffen Heeger, Christian Lüpfert, Udo Vanhoefer

Invest New Drugs· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Gastrointestinal tumors--interdisciplinary discussion over new data].
Dirk Arnold, Rainer Fietkau, Susanna Hegewisch-Becker, Thomas Höhler, Wolfram Trudo Knoefel, Udo Vanhoefer

Onkologie· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Tanja Trarbach, Anke Reinacher-Schick, Susanne Hegewisch-Becker, Udo Vanhoefer, Thomas Frieling

Onkologie· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Palliative treatment for colorectal cancer].
Susanna Hegewisch-Becker, Udo Vanhoefer, Stefan Kubicka, Maciej Pech, Markus Moehler

Onkologie· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical predictive factors.
Claus-Henning Köhne, Udo Vanhoefer, Gernot Hartung

Eur J Cancer· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly infusional high-dose fluorouracil (HD-FU), HD-FU plus folinic acid (HD-FU/FA), or HD-FU/FA plus biweekly cisplatin in advanced gastric cancer: randomized phase II trial 40953 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group and the Arbeitsgemeinschaft Internistische Onkologie.
Manfred P Lutz, Hansjochen Wilke, D J Theo Wagener, Udo Vanhoefer, Krzysztof Jeziorski

J Clin Oncol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphological and functional evaluation of angiogenesis of a xenografted human sarcoma in nude mice.
Christoph Pöttgen, Gero Hilken, Udo Vanhoefer, Martin Stuschke, Georg Stüben

Lab Anim· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanisms and targeting of colorectal cancer.
Udo Vanhoefer

Semin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.
Manfred P Lutz, Eric Van Cutsem, Theo Wagener, Jean-Luc Van Laethem, Udo Vanhoefer

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan.
Ada Henrike Braun, Katrin Stark, Olaf Dirsch, Ralf Axel Hilger, Siegfried Seeber, Udo Vanhoefer

Anticancer Drugs· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hypoglycemia caused by paraneoplastic production of IGF-II in patients with advanced gastrointestinal stromal tumors: a report of two cases.
Daniel Pink, Dagmar Schoeler, Tanja Lindner, Peter C Thuss-Patience, Albrecht Kretzschmar, Udo Vanhoefer

J Clin Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response to induction chemotherapy predicts local control and long-term survival in multimodal treatment of patients with locally advanced esophageal cancer.
Michael Stahl, Hansjochen Wilke, Martin Stuschke, Martin K Walz, Ulrich Fink, Udo Vanhoefer

J Cancer Res Clin Oncol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New systemic frontline treatment for metastatic colorectal carcinoma.
Ada H Braun, Wolf Achterrath, Hansjochen Wilke, Udo Vanhoefer, Andreas Harstrick

Cancer· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the humanized antiepidermal growth factor receptor monoclonal antibody EMD72000 in patients with advanced solid tumors that express the epidermal growth factor receptor.
Udo Vanhoefer, Mitra Tewes, Federico Rojo, Olaf Dirsch, Norbert Schleucher

J Clin Oncol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584.
Anne L Thomas, Bruno Morgan, Joachim Drevs, Clemens Unger, Bertram Wiedenmann, Udo Vanhoefer

Semin Oncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-aroylindoles, a novel class of potent, orally active small molecule tubulin inhibitors.
Thomas Beckers, Thomas Reissmann, Mathias Schmidt, Angelika M Burger, Heinz H Fiebig, Udo Vanhoefer

Cancer Res· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis